Short Interest in Arch Therapeutics, Inc. (OTCMKTS:ARTH) Declines By 6.1%

Arch Therapeutics, Inc. (OTCMKTS:ARTH) saw a significant drop in short interest in November. As of November 30th, there was short interest totalling 12,400 shares, a drop of 6.1% from the November 15th total of 13,200 shares. Based on an average daily trading volume, of 9,000 shares, the days-to-cover ratio is presently 1.4 days.

Arch Therapeutics Stock Up 16.7 %

Shares of OTCMKTS ARTH opened at $0.23 on Wednesday. Arch Therapeutics has a 1-year low of $0.17 and a 1-year high of $9.00. The company has a 50-day moving average of $0.27 and a two-hundred day moving average of $0.58.

Arch Therapeutics Company Profile

Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.